title: Cystic fibrosis in adolescents and adults.
abstract: A cystic fibrosis (CF) clinic for adults was established in 1977. We have reviewed the data on 164 patients who attended between 1977 and 1989. Twenty four patients had died, 11 being over 20 years after time of death. Of the 140 patients still alive, 61% were male and 53% were aged over 20 years. Only 55% were diagnosed by 1 year and 88% by 10 years. Almost all patients had respiratory symptoms and sputum culture yielded Pseudomonas species in 69%. Other respiratory problems included major haemoptysis and pneumothorax, each in 10%. We found a wide range of respiratory impairment among older patients. Among 3 patients aged over 23 years the mean (+/- S.D.) percent predicted FEV1 and FVC were 53.3% (+/- 18%) and 71.4% (+/- 20%) respectively. Mean weight in this group was 92.5% (+/- 14) of predicted. Malabsorption occurred in most patients and meconium ileus equivalent occurred in most patients and meconium ileus equivalent occurred in 34%. Other complications were clinical hepatomegaly (16%), diabetes mellitus (9%) and arthropathy (20%). Most patients were taking continuous antibiotics by mouth (89%) and by nebuliser (48%), beta-2 agonists by inhaler (57%) and oral steroids (29%). Almost all were taking multivitamins, pancreatic replacement therapy and multiple nutritional supplements. The number of CF "bed days" grew 12 fold since 1979 and the mean stay in hospital was double the hospital mean. The economic impact was such that over 1/4 of the annual hospital antibiotic budget was expended on CF patients.
authors.affiliation: Adult Cystic Fibrosis Clinic, University College Dublin, St Vincent's Hospital.
authors.forename: D
authors.initials: D
authors.lastname: Mulherin
authors.forename: K
authors.initials: K
authors.lastname: Ward
authors.forename: M
authors.initials: M
authors.lastname: Coffey
authors.forename: M T
authors.initials: MT
authors.lastname: Keoghan
authors.forename: M
authors.initials: M
authors.lastname: Fitzgerald
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology; D005260:Female; D006801:Humans; D007223:Infant; D007494:Ireland / Q000453:epidemiology; D008297:Male; D012141:Respiratory Tract Infections / Q000150:complications / Q000191:economics / Q000382:microbiology; D012189:Retrospective Studies; D012737:Sex Factors; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents